9969 — InnoCare Pharma Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$12.16bn
- HK$5.71bn
- CNY738.54m
- 11
- 12
- 87
- 25
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 93.5 | -126 | -250 | -409 | -562 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -20.5 | -298 | 167 | -491 | -665 |
Capital Expenditures | -66.1 | -229 | -171 | -370 | -255 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 53.2 | -871 | -1,543 | -1,431 | 916 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -12.9 | -1,100 | -1,714 | -1,801 | 661 |
Financing Cash Flow Items | -13 | -16.4 | -32.7 | -154 | -38.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 359 | 2,238 | 2,545 | 3,095 | 1.31 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 344 | 696 | 952 | 942 | 22.6 |